1. Driver, JA, Viswanathan, AN. Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older. Gynecol Oncol 2017; 145(3): 526–530.
Google Scholar | Crossref | Medline2. Wilson, S, Sharp, CA, Davie, MW. Health-related quality of life in patients with osteoporosis in the absence of vertebral fracture: a systematic review. Osteoporos Int 2012; 23(12): 2749–2768.
Google Scholar | Crossref | Medline3. Harvey, NC, McCloskey, EV, Mitchell, PJ, et al. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int 2017; 28(5): 1507–1529.
Google Scholar | Crossref | Medline4. Coleman, R, Hadji, P, Body, J-J, et al. Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol 2020; 31: 1650–1663.
Google Scholar | Crossref | Medline5. Shapiro, CL, Van Poznak, C, Lacchetti, C, et al. Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline. J Clin Oncol 2019; 37: 2916–2946.
Google Scholar | Crossref | Medline6. Hadji, P, Aapro, MS, Body, JJ, et al. Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol 2017; 7: 1–12.
Google Scholar | Crossref | Medline7. Tang, BM, Eslick, GD, Nowson, C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370: 657–666.
Google Scholar | Crossref | Medline | ISI8. Prieto-Alhambra, D, Servitja, S, Javaid, MK, et al. Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study. Breast Cancer Res Treat 2012; 133(3): 1159–1167.
Google Scholar | Crossref | Medline9. Harrington, J. Dilemmas in providing osteoporosis care for fragility fracture patients. US Musculoskelet Rev Touch Brief 2006; 2: 64–65.
Google Scholar10. Spangler, L, Yu, O, Loggers, E, et al. Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors. J Womens Health 2013; 22(2): 132–140.
Google Scholar | Crossref11. Damji, AN, Bies, K, Alibhai, SM, et al. Bone health management in men undergoing ADT: examining enablers and barriers to care. Osteoporos Int 2015; 26(3): 951–959.
Google Scholar | Crossref | Medline12. Suarez-Almazor, ME, Peddi, P, Luo, R, et al. Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy. Support Care Cancer 2014; 22(2): 537–544.
Google Scholar | Crossref | Medline13. Hadjidakis, D, Kokkinakis, E, Sfakianakis, M, et al. The type and time of menopause as decisive factors for bone mass changes. Eur J Clin Invest 1999; 29(10): 877–885.
Google Scholar | Crossref | Medline | ISI14. res Sapienza, LG, Salcedo, MP, Ning, MS, et al. Pelvic insufficiency fractures after external beam radiation therapy for gynecologic cancers: a meta-analysis and meta-regression of 3929 patients. Int J Radiat Oncol Biol Phys 2020; 106: 475–484.
Google Scholar | Crossref | Medline15. Nishio, K, Tanabe, A, Maruoka, R, et al. Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women. Endocr Connect 2013; 2: 11–17.
Google Scholar | Crossref | Medline16. Lee, JE, Ji, YI. P164 Reduction of bone mineral density and risk of osteoporosis in gynecologic cancer patients. Int J Gynecol Cancer 2019; 29: A159.
Google Scholar17. Lee, Y, Kim, A, Kim, HY, et al. Bone density in patients with cervical cancer or endometrial cancer in comparison with healthy control; according to the stages. J Cancer 2015; 6: 686–693.
Google Scholar | Crossref | Medline18. Hernlund, E, Svedbom, A, Ivergard, M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 2013; 8: 136.
Google Scholar | Crossref | Medline | ISI19. Salcedo, MP, Sood, AK, Jhingran, A, et al. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: a prospective study of 239 women. Cancer 2020; 126: 2607–2613.
Google Scholar | Crossref | Medline20. Laird, E, O’Halloran, AM, Carey, D, et al. The prevalence of vitamin D deficiency and the determinants of 25(OH)D concentration in older Irish adults: data from the Irish longitudinal study on ageing (TILDA). J Gerontol Series A 2017; 73: 519–525.
Google Scholar | Crossref21. Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96(7): 1911–1930.
Google Scholar | Crossref | Medline | ISI22. Hauser, K, Walsh, D, Shrotriya, S, et al. Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg. Support Care Cancer 2014; 22(7): 1931–1939.
Google Scholar | Crossref | Medline23. Grant, WB, Mohr, SB. Ecological studies of ultraviolet B, Vitamin D and cancer since 2000. Ann Epidemiol 2009; 19(7): 446–454.
Google Scholar | Crossref | Medline24. Martin-Herranz, A, Salinas-Hernandez, P. Vitamin D supplementation review and recommendations for women diagnosed with breast or ovary cancer in the context of bone health and cancer prognosis/risk. Crit Rev Oncol Hematol 2015; 96(1): 91–99.
Google Scholar | Crossref | Medline25. Walentowicz-Sadlecka, M, Grabiec, M, Sadlecki, P, et al. 25(OH)D3 in patients with ovarian cancer and its correlation with survival. Clin Biochem 2012; 45(18): 1568–1572.
Google Scholar | Crossref | Medline26. Hadji, P, Aapro, M, Body, J-J, et al. Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Ann Oncol 2011; 22(12): 2546–2555.
Google Scholar | Crossref | Medline27. Hadji, P, Gnant, M, Body, J-J, et al. Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention. Cancer Treat Rev 2012; 38(6): 798–806.
Google Scholar | Crossref | Medline28. D’Oronzo, S, Stucci, S, Tucci, M, et al. Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications. Cancer Treat Rev 2015; 41(9): 798–808.
Google Scholar | Crossref | Medline29. Sperling, C, Sandager, M, Jensen, H, et al. Current organisation of follow-up does not meet cancer patients’ needs. Dan Med J 2014; 61: A4855.
Google Scholar | Medline30. McCallum, M, Lynne Jolicoeur, R, Monique Lefebvre, C, et al. Supportive care needs after gynecologic cancer: where does sexual health fit in? Oncol Nurs Forum 2014; 41: 297–306.
Google Scholar | Crossref | Medline31. Zhumkhawala, AA, Gleason, JM, Cheetham, TC, et al. Osteoporosis management program decreases incidence of hip fracture in patients with prostate cancer receiving androgen deprivation therapy. Urology 2013; 81(5): 1010–1015.
Google Scholar | Crossref | Medline32. Rizzoli, R, Body, JJ, Brandi, ML, et al. Cancer-associated bone disease. Osteoporos Int 2013; 24: 2929–2953.
Google Scholar | Crossref | Medline | ISI33. Mithal, A, Bansal, B, Kyer, CS, et al. The Asia-Pacific regional audit-epidemiology, costs, and burden of osteoporosis in India 2013: a report of international osteoporosis foundation. Indian J Endocrinol Metab 2014; 18(4): 449–454.
Google Scholar | Crossref | Medline34. Rizzoli, R, Body, JJ, DeCensi, A, et al. Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper. Osteoporos Int 2012; 23(11): 2567–2576.
Google Scholar | Crossref | Medline35. Salminen, H, Piispanen, P, Toth -Pal, E. Primary care physicians’ views on osteoporosis management: a qualitative study. Arch Osteoporos 2019; 14: 48.
Google Scholar | Crossref | Medline36. Otmar, R, Reventlow, SD, Nicholson, GC, et al. General medical practitioners’ knowledge and beliefs about osteoporosis and its investigation and management. Arch Osteoporos 2012; 7: 107–114.
Google Scholar | Crossref | Medline37. American College of Surgeons CoC . Standards Manual, https://www.facs.org/~/media/files/quality%20programs/cancer/coc/omh%20manual.ashx (2020, accessed 5 April 2020).
Google Scholar38. Yamamoto, K, Nagao, S, Suzuki, K, et al. Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: a retrospective analysis of risk factors. Gynecol Oncol 2017; 147(3): 585–588.
Google Scholar | Crossref | Medline39. Newton, C, Nordin, A, Rolland, P, et al. British gynaecological cancer society recommendations and guidance on patient-initiated follow-up (PIFU). Int J Gynecol Cancer 2020; 30(5): 695–700.
Google Scholar | Crossref | Medline